NQO1 and cancer: Although its uptake and inhibitory and potentially off-target effects of NQO1 in humans still has to be tested to confirm its suitability for cancer therapy, its in vitro and in vivo properties, even including its potential to induce DSBs, are promising to be used to radiosensitize cancer cells and to hamper DSB-repair.